Product Information
VOQUEZNA DUAL PAK is a brand product labeled by Phathom Pharmaceuticals Inc., priced at $7.4846 per EA under NDC 81520025014. Its NADAC has been published 75 times since Jan 22, 2025.
Manufacturer
Phathom Pharmaceuticals Inc.NDC
81520025014
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA215153On Market Since
11/8/2023
Price Statistics
The NADAC for VOQUEZNA DUAL PAK has been published 75 times since Jan 22, 2025, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4846 per EA |
|---|---|
| All-time high | $7.5295 (May 13, 2026) |
| All-time low | $7.3036 (Jan 22, 2025) |
| 52-week high | $7.5295 |
| 52-week low | $7.3036 |
| Median price | $7.3036 |
| Average price | $7.3766 |
| Largest weekly change | +3.0% (Jan 7, 2026) |
| Weeks tracked | 75 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the vonoprazan fumarate and amoxicillin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VOQUEZNA DUAL PAK?
The current National Average Drug Acquisition Cost (NADAC) for VOQUEZNA DUAL PAK, manufactured by Phathom Pharmaceuticals Inc., is $7.4846 per EA (NDC 81520025014), effective Jun 24, 2026.
How has the price of VOQUEZNA DUAL PAK changed over time?
Over the history we have for it, the NADAC for VOQUEZNA DUAL PAK has risen 2.5%. It has been tracked across 75 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for VOQUEZNA DUAL PAK?
Since Jan 22, 2025, the NADAC for VOQUEZNA DUAL PAK has ranged from a low of $7.3036 (Jan 22, 2025) to a high of $7.5295 (May 13, 2026), with a median of $7.3036 per EA.
Are there cheaper alternatives to VOQUEZNA DUAL PAK?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VOQUEZNA DUAL PAK, so no direct lower-cost alternative is listed.
Who manufactures VOQUEZNA DUAL PAK?
VOQUEZNA DUAL PAK (NDC 81520025014) is labeled by Phathom Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification